Claudia Heilmann1, Friedhelm Beyersdorf, Georg Lutter
1Department of Surgery, School of Medicine, Albert-Ludwigs-University Freiburg, Freiburg, Germany.
New therapies are needed for end-stage coronary artery disease (CAD) and peripheral artery occlusion disease when bypass surgery isn't an option. This review explores collateral vessel development and key cell types for treating ischemic conditions.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: